• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Small Innovators & Niche CROs

    Focus on Science

    Rapid and Data Rich Chromatographic Method Development

    Preparing Your Post Pandemic Talent Strategy

    How Modern Near-Infrared Came to Be
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ

    Ascendia Pharmaceuticals Poised for Expansion

    Bora Pharmaceuticals Adds Roller Compaction Capabilities

    Merck KGaA Selects PRA’s Remote Patient Monitoring Platform

    AGC Biologics Appoints Jun Takami GM of Chiba Site
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Ascendia Pharmaceuticals Poised for Expansion

    Bora Pharmaceuticals Adds Roller Compaction Capabilities

    Alkermes, Merck Enter Clinical Trial and Supply Agreement

    Sterling Pharma Solutions Acquires ADC Biotechnology

    Moderna, Catalent Enter Long-Term Strategic Vax Pact
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Cryoport Acquires Critical Transport Solutions Australia

    PharmParts – This Makes Sense!

    Securing Your API Supply Chain: Three Keys to Success

    Enteris BioPharma: Custom Solutions – From Bench to Market

    The Benefits of Outsourcing Cold Storage
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ

    Ascendia Pharmaceuticals Poised for Expansion

    Merck KGaA Selects PRA’s Remote Patient Monitoring Platform

    Agilex Biolabs Acquires TetraQ for APAC Expansion Plans

    Alkermes, Merck Enter Clinical Trial and Supply Agreement
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    What Will Change at FDA for 2021?

    RBQM Comes of Age: COVID as a Catalyst for Change

    Post-Pandemic Regulations

    Enteris BioPharma: Custom Solutions – From Bench to Market

    Metrics Contract Services Completes Russian Regulatory Inspection
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    PCI Pharma Services

    Adare Pharma Solutions

    Aphena Pharma Solutions

    Almac Group

    Reed-Lane
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Aphena Pharma Solutions

    Adare Pharma Solutions

    Reed-Lane

    Quotient Sciences

    Baxter BioPharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    PPD, Clinical Ink Partner on Near Real-Time Access to Endpoint Data

    Jointly develop systemic lupus erythematosus assessment review process to enhance data quality and research site personnel experiences and efficiencies.

    Related CONTENT
    • Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    • Ascendia Pharmaceuticals Poised for Expansion
    • Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
    • Imvax Appoints Sean Hemingway Chief Operating Officer
    • ANI Acquires Branded Products Portfolio from Sandoz
    Kristin Brooks03.24.21
    PPD, Inc., a global CRO, and Clinical Ink, a global clinical technology company, have jointly developed a systemic lupus erythematosus (SLE) assessment review process designed to simplify operationalizing clinical trials for this chronic autoimmune disease. The companies’ approach focuses on enhancing data quality and research site personnel experiences and efficiencies.
     
    The data collection is a customized PPD version of Clinical Ink's electronic Lupus Assessment Suite (eLAS). Using eLAS is designed to simplify investigator and patient participation in clinical trials and provides pharma customers with near real-time access to SLE endpoint data.
     
    Clinical Ink’s eLAS is a therapeutic-specific application of its Lunexis platform, featuring an integrated suite of SLE disease assessment questionnaires and patient-reported outcomes that are completed by clinicians and patients. With eLAS, investigators enter patient data once and the system automatically populates the appropriate fields across the required assessments, reducing redundant data entries and errors, which saves time and enhances site efficiencies.
     
    “Combining PPD’s team of SLE operational and clinical experts with Clinical Ink’s proprietary eLAS solution enables us to offer near real-time access to critical SLE endpoint data,” said Carol Olson, M.D., Ph.D., vice president and head of global product development at PPD. “This consolidated approach addresses one of the most important challenges in SLE studies related to the variability of placebo response and improves efficacy signal detection. It also enables us to conduct a central review of key data by a dedicated team, enhancing the accuracy and consistency of our results.”
     
    Related Searches
    • Information Technology
    • Clinical Trials
    Suggested For You
    Ascendia Pharmaceuticals Poised for Expansion Ascendia Pharmaceuticals Poised for Expansion
    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    Merck KGaA Selects PRA’s Remote Patient Monitoring Platform Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
    Imvax Appoints Sean Hemingway Chief Operating Officer Imvax Appoints Sean Hemingway Chief Operating Officer
    ANI Acquires Branded Products Portfolio from Sandoz ANI Acquires Branded Products Portfolio from Sandoz
    Sterling Pharma Solutions Acquires ADC Biotechnology Sterling Pharma Solutions Acquires ADC Biotechnology
    Moleculin Selects IQVIA Biotech to Advance COVID Treatment Moleculin Selects IQVIA Biotech to Advance COVID Treatment
    Cryoport Acquires Critical Transport Solutions Australia Cryoport Acquires Critical Transport Solutions Australia
    Sanofi to Build New $700M Flu Vaccine Facility in Canada Sanofi to Build New $700M Flu Vaccine Facility in Canada
    What Will Change at FDA for 2021? What Will Change at FDA for 2021?
    Servier Acquires Agios Pharmaceuticals’ Oncology Portfolio Servier Acquires Agios Pharmaceuticals’ Oncology Portfolio
    Eloxx Pharmaceuticals Acquires Zikani Therapeutics Eloxx Pharmaceuticals Acquires Zikani Therapeutics
    Lonza Completes Divestment of Sites to NextPharma Lonza Completes Divestment of Sites to NextPharma
    EMA Approves BioNTech EMA Approves BioNTech's COVID Vax Production at Marburg Site
    mAbxience Bolsters Biosimilar and CDMO Manufacturing Capacity mAbxience Bolsters Biosimilar and CDMO Manufacturing Capacity

    Related Breaking News

    • Breaking News | Clinical Trials | CRO News | Industry News
      Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ

      Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ

      Offers full-service human absorption, metabolism, and excretion (hAME) studies with radiolabeled compounds.
      Tim Wright, Editor, Contract Pharma 04.09.21

    • Breaking News | Clinical Trials | CRO News
      Merck KGaA Selects PRA’s Remote Patient Monitoring Platform

      Merck KGaA Selects PRA’s Remote Patient Monitoring Platform

      Adding layer of technology to HGH treatments aims to facilitate better patient compliance.
      Kristin Brooks 04.08.21

    • Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
      Alkermes, Merck Enter Clinical Trial and Supply Agreement

      Alkermes, Merck Enter Clinical Trial and Supply Agreement

      To evaluate nemvaleukin alfa in combination with Keytruda in patients with platinum-resistant ovarian cancer.
      Tim Wright, Editor, Contract Pharma 04.07.21


    • Bio News | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | Information Technology
      Hitachi, Axcelead to Develop Next-Gen Biopharmaceuticals

      Hitachi, Axcelead to Develop Next-Gen Biopharmaceuticals

      Supporting R&D optimization of next-generation biopharmaceuticals with digital technology and drug discovery platform.
      Tim Wright, Editor, Contract Pharma 04.07.21

    • Breaking News | Clinical Trials | Drug Development | Industry News
      Sound Pharmaceuticals Receives $3.1M NIH Grant for COVID Treatment

      Sound Pharmaceuticals Receives $3.1M NIH Grant for COVID Treatment

      To support the testing of SPI-1005 in two Phase 2 clinical trials for the treatment of COVID-19.
      Kristin Brooks 04.06.21

    • Breaking News | Clinical Trials | CRO News | Drug Development
      Moleculin Selects IQVIA Biotech to Advance COVID Treatment

      Moleculin Selects IQVIA Biotech to Advance COVID Treatment

      IQVIA to manage the company's effort to begin potential clinical trials of WP1122 for the treatment of COVID-19.
      Kristin Brooks 04.06.21


    • Breaking News | Industry News | Information Technology
      LabVantage Solutions Expands and Improves its Portfolio

      LabVantage Solutions Expands and Improves its Portfolio

      Unveils two new solutions and an updated version of its flagship LIMS platform.
      Charles Sternberg, Assistant Editor 04.05.21

    • Breaking News | Industry News | Information Technology | Promotions & Moves
      LabVantage Solutions Names Mikael Hagstroem as CEO

      LabVantage Solutions Names Mikael Hagstroem as CEO

      Brings almost 30 years of experience as a pioneer and expert in digital transformation.
      Tim Wright, Editor, Contract Pharma 03.25.21

    • Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Trials & Filings
      CureVac Expands Late-stage Trials of COVID Vax Candidate

      CureVac Expands Late-stage Trials of COVID Vax Candidate

      Further analysis to determine efficacy of the vaccine candidate for new virus variants.
      Krisitn Brooks 03.22.21


    • Breaking News | Clinical Trials | Drug Development | Trials & Filings
      Gilead, Novo Nordisk Expand NASH Alliance

      Gilead, Novo Nordisk Expand NASH Alliance

      Phase II trial to investigate Novo’s semaglutide and a combination of Gilead’s cilofexor and firsocostat, alone and in combination in cirrhosis due to NASH.
      Kristin Brooks 03.18.21

    • Breaking News | Clinical Trials | Drug Development | Trials & Filings
      Cytocom Gets FDA Clearance for Phase II Trial of COVID Immune Therapy

      Cytocom Gets FDA Clearance for Phase II Trial of COVID Immune Therapy

      Phase 2 clinical trial to evaluate the safety and efficacy of CYTO-205 as a treatment to slow or halt the progression of SARS-CoV-2.
      Kristin Brooks 03.16.21

    • Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Industry News
      Novavax Confirms Efficacy Against Original and Variant COVID-19 Strains

      Novavax Confirms Efficacy Against Original and Variant COVID-19 Strains

      Final analysis of NVX–CoV2373 in UK trial confirms 96% efficacy against original strain of COVID-19 and 86.3% against the B.1.1.7 variant.
      Kristin Brooks 03.12.21


    • Breaking News | Clinical Trials
      Strata Oncology Unveils Strata PATH Trial

      Strata Oncology Unveils Strata PATH Trial

      The new platform clinical trial will evaluate FDA-approved therapies in novel biomarker profiles learned from real-world data.
      Charles Sternberg, Assistant Editor 03.02.21

    • Breaking News | Clinical Trials | CRO News | Information Technology
      Alimentiv Acquires McDougall Scientific

      Alimentiv Acquires McDougall Scientific

      Niche CRO specializes in statistical analysis, data management, reporting, and clinical trial design.
      Kristin Brooks 03.02.21

    • Breaking News | Clinical Trials | Collaborations & Alliances | Industry News | Information Technology
      Ashfield Engage, Popit Form Digital Monitoring Collaboration

      Ashfield Engage, Popit Form Digital Monitoring Collaboration

      Partner to improve patient adherence through supplemental real-time personalized support.
      Tim Wright, Editor, Contract Pharma 02.26.21

    Trending
    • Sterling Pharma Solutions Acquires ADC Biotechnology
    • Sanofi To Build New $700M Flu Vaccine Facility In Canada
    • Alkermes, Merck Enter Clinical Trial And Supply Agreement
    • Ascendia Pharmaceuticals Poised For Expansion
    • Frontage Expands Capabilities At Its Clinical Site In Secaucus, NJ
    Breaking News
    • Bora Pharmaceuticals Adds Roller Compaction Capabilities
    • Ascendia Pharmaceuticals Poised for Expansion
    • Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    • Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
    • AGC Biologics Appoints Jun Takami GM of Chiba Site
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Small Innovators & Niche CROs
    • Focus on Science
    • Rapid and Data Rich Chromatographic Method Development
    • Preparing Your Post Pandemic Talent Strategy
    • How Modern Near-Infrared Came to Be
    • Securing Your API Supply Chain: Three Keys to Success
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health
    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status
    Nutritional Complex Evidenced to Reduce Preterm Birth
    Coatings World

    Latest Breaking News From Coatings World

    Barentz Expands Canadian CASE Team
    Shepherd Color Company Opens Sales Office in China
    Chromaflo Technologies Awarded Gold Status CSR Rating by EcoVadis in EMEA
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CMS Establishes New Payment for Pelvalon’s Eclipse System
    Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy
    Resonetics Leases New Manufacturing Space in Costa Rica
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    Ascendia Pharmaceuticals Poised for Expansion
    Bora Pharmaceuticals Adds Roller Compaction Capabilities
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Revlon Unveils New Fragrances Featuring Megan Thee Stallion & Sofia Carson
    Henkel Management Board Welcomes Wolfgang König
    Mielle Organics Gets a Major Investment
    Happi

    Latest Breaking News From Happi

    Nature’s Beauty Debuts Vegan Natural Body Care at Walgreens
    Estée Lauder Expands 'Beautiful' Fagrance Collection
    Mushrooms Are Key Ingredients in Beauty & Wellness
    Ink World

    Latest Breaking News From Ink World

    SE-DA Invests in Kornit Presto S
    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    Iron Oxide Pigments Market to Register 4.7% CAGR from 2021 to 2028: GVR
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Dantex elevates Joseph Sanchez to digital business development manager
    Mactac's Kevin Clunie joins TLMI panel
    MacDermid announces two new global sales roles
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Precision Textiles Offers Biodegradable Medical Fabric
    Northshore Launches Megamax Briefs in New Colors
    Essity Acquires Distribution Rights to Sorbact in Australia and New Zealand
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    New Biosealant Could Stabilize Cartilage, Boost Healing After Injury
    Google Executive Joins SeaSpine's Board of Directors
    HSS and LimaCorporate Open Provider-Based 3D Design and Printing Facility
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Tive Multi-sensor Tracker Solo 5G Relies on Sensirion SHT33
    VTT in 2020: Successful Year Despite Globally Challenging Times
    Lux Research: 3D Printing Market to Reach $51 Billion in 2030

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login